Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 42, Issue 6 (May 2017) In this issue Commentary Original Articles Also new AOP Facebook Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Open for Submissions An interdisciplinary journal dedicated to publishing high-quality open research relevant to all aspects of schizophrenia and psychosis. Explore the benefits of submitting your next research article. Commentary Top Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders G Sanacora, H Heimer, D Hartman, S J Mathew, M Frye, C Nemeroff and R Robinson Beale Neuropsychopharmacology 2017 42: 1179-1181; advance online publication, October 12, 2016; 10.1038/npp.2016.193 Full Text Original Articles Top Genetic and Modeling Approaches Reveal Distinct Components of Impulsive Behavior Katherine M Nautiyal, Melanie M Wall, Shuai Wang, Valerie M Magalong, Susanne E Ahmari, Peter D Balsam, Carlos Blanco and René Hen Neuropsychopharmacology 2017 42: 1182-1191; advance online publication, January 18, 2017; 10.1038/npp.2016.277 Abstract | Full Text Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy Won H Lee, Sarah H Lisanby, Andrew F Laine and Angel V Peterchev Neuropsychopharmacology 2017 42: 1192-1200; advance online publication, January 25, 2017; 10.1038/npp.2016.276 Abstract | Full Text Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities Meng Li, Liliana Ramona Demenescu, Lejla Colic, Coraline Danielle Metzger, Hans-Jochen Heinze, Johann Steiner, Oliver Speck, Anna Fejtova, Giacomo Salvadore and Martin Walter Neuropsychopharmacology 2017 42: 1201-1209; advance online publication, October 19, 2016; 10.1038/npp.2016.184 Abstract | Full Text Ketamine Treatment and Global Brain Connectivity in Major Depression Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang, Dan V Iosifescu, Dennis S Charney and James W Murrough Neuropsychopharmacology 2017 42: 1210-1219; advance online publication, October 12, 2016; 10.1038/npp.2016.186 Abstract | Full Text Ketamine Corrects Stress-Induced Cognitive Dysfunction through JAK2/STAT3 Signaling in the Orbitofrontal Cortex Michael S Patton, Daniel J Lodge, David A Morilak and Milena Girotti Neuropsychopharmacology 2017 42: 1220-1230; advance online publication, November 9, 2016; 10.1038/npp.2016.236 Abstract | Full Text GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine Rong-Jian Liu, Catharine Duman, Taro Kato, Brendan Hare, Dora Lopresto, Eunyoung Bang, Jeffery Burgdorf, Joseph Moskal, Jane Taylor, George Aghajanian and Ronald S Duman Neuropsychopharmacology 2017 42: 1231-1242; advance online publication, October 19, 2016; 10.1038/npp.2016.202 Abstract | Full Text Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner Morgan S Bridi, Joshua D Hawk, Snehajyoti Chatterjee, Stephen Safe and Ted Abel Neuropsychopharmacology 2017 42: 1243-1253; advance online publication, December 7, 2016; 10.1038/npp.2016.253 Abstract | Full Text Impact of Stress and Glucocorticoids on Schema-Based Learning Lisa Marieke Kluen, Patricia Nixon, Agorastos Agorastos, Klaus Wiedemann and Lars Schwabe Neuropsychopharmacology 2017 42: 1254-1261; advance online publication, December 14, 2016; 10.1038/npp.2016.256 Abstract | Full Text Stress Induces a Shift Towards Striatum-Dependent Stimulus-Response Learning via the Mineralocorticoid Receptor Susanne Vogel, Floris Klumpers, Tobias Navarro Schröder, Krista T Oplaat, Harm J Krugers, Melly S Oitzl, Marian Joëls, Christian F Doeller and Guillén Fernández Neuropsychopharmacology 2017 42: 1262-1271; advance online publication, December 21, 2016; 10.1038/npp.2016.262 Abstract | Full Text GABAb Receptor Mediates Opposing Adaptations of GABA Release From Two Types of Prefrontal Interneurons After Observational Fear Lei Liu, Wataru Ito and Alexei Morozov Neuropsychopharmacology 2017 42: 1272-1283; advance online publication, January 4, 2017; 10.1038/npp.2016.273 Abstract | Full Text Context and Auditory Fear are Differentially Regulated by HDAC3 Activity in the Lateral and Basal Subnuclei of the Amygdala Janine L Kwapis, Yasaman Alaghband, Alberto J López, André O White, Rianne R Campbell, Richard T Dang, Diane Rhee, Ashley V Tran, Allison E Carl, Dina P Matheos and Marcelo A Wood Neuropsychopharmacology 2017 42: 1284-1294; advance online publication, January 4, 2017; 10.1038/npp.2016.274 Abstract | Full Text Sex Differences in μ-Opioid Receptor Regulation of the Rat Locus Coeruleus and Their Cognitive Consequences OPEN Herminio M Guajardo, Kevin Snyder, Andrew Ho and Rita J Valentino Neuropsychopharmacology 2017 42: 1295-1304; advance online publication, December 14, 2016; 10.1038/npp.2016.252 Abstract | Full Text Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition Michael D Schwartz, Sarah W Black, Simon P Fisher, Jeremiah B Palmerston, Stephen R Morairty, Marius C Hoener and Thomas S Kilduff Neuropsychopharmacology 2017 42: 1305-1314; advance online publication, October 26, 2016; 10.1038/npp.2016.216 Abstract | Full Text Chemogenetic Activation of Midbrain Dopamine Neurons Affects Attention, but not Impulsivity, in the Five-Choice Serial Reaction Time Task in Rats Linde Boekhoudt, Elisa S Voets, Jacques P Flores-Dourojeanni, Mieneke CM Luijendijk, Louk JMJ Vanderschuren and Roger AH Adan Neuropsychopharmacology 2017 42: 1315-1325; advance online publication, November 16, 2016; 10.1038/npp.2016.235 Abstract | Full Text Methylphenidate Enhances Early-Stage Sensory Processing and Rodent Performance of a Visual Signal Detection Task Rachel L Navarra, Brian D Clark, Andrew T Gargiulo and Barry D Waterhouse Neuropsychopharmacology 2017 42: 1326-1337; advance online publication, January 4, 2017; 10.1038/npp.2016.267 Abstract | Full Text Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task Jared W Young, Andrew W Bismark, Yinming Sun, Wendy Zhang, Meghan McIlwain, Ibrahim Grootendorst and Gregory A Light Neuropsychopharmacology 2017 42: 1338-1348; advance online publication, February 8, 2017; 10.1038/npp.2016.268 Abstract | Full Text Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes Emilie I Petit, Zuzanna Michalak, Rachel Cox, Colm M P O’Tuathaigh, Niamh Clarke, Orna Tighe, Konrad Talbot, Derek Blake, Josephine Joel, Alexander Shaw, Steven A Sheardown, Alastair D Morrison, Stephen Wilson, Ellen M Shapland, David C Henshall, James N Kew, Brian P Kirby and John L Waddington Neuropsychopharmacology 2017 42: 1349-1360; advance online publication, January 25, 2017; 10.1038/npp.2016.282 Abstract | Full Text Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study OPEN New Fei Ho, Daphne J Holt, Mike Cheung, Juan Eugenio Iglesias, Alex Goh, Mingyuan Wang, Joseph KW Lim, Joshua de Souza, Joann S Poh, Yuen Mei See, Alison R Adcock, Stephen J Wood, Michael WL Chee, Jimmy Lee and Juan Zhou Neuropsychopharmacology 2017 42: 1361-1370; advance online publication, February 1, 2017; 10.1038/npp.2017.5 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.